A multicultural group practicing yoga together in a bright studio

Sprout Health vs Trimi: GLP-1 Comparison 2026

Sprout Health vs Trimi: pricing, medication type, clinical support, and which budget-conscious GLP-1 patient each program fits. Both programs’ prices verified August 2026 or later; each price carries its own date in the table below.

By RangeYourselfUpdated October 6, 20264 min read

Quick answer

Trimi typically wins on sticker price for compounded GLP-1. Choose Trimi if you're price-first; choose Sprout Health if you want brand-name (FDA-approved) access.

Side-by-side comparison

Feature	Sprout Health	Trimi
Best for	Balance of price and clinical support	Lowest-cost compounded GLP-1 on an annual plan with a plain 503A disclosure
Medication type	Compounded semaglutide and tirzepatide; brand-name Wegovy/Zepbound listed cash-pay	Compounded semaglutide and compounded tirzepatide, once-weekly at-home injection
Pricing model	12-month plan billed every 12 months, or a monthly plan billed every 4 weeks; Sprout states the same price at any dose (homepage, 2026-10-06)	Flat-membership subscription billed yearly (annual commitment tier); one price covers medication, clinician visits, check-ins, shipping; no separate membership fee; no insurance
Semaglutide price	From $99/mo on the 12-month plan (billed $1,188 every 12 months); $149 per 4 weeks on the monthly plan; same price at any dose (compounded semaglutide, homepage-verified 2026-10-06)	Compounded, $99/mo on the annual plan, BILLED YEARLY ($1,188/yr up front). Verified 2026-08-21 (unchanged since 2026-07-14).
Tirzepatide price	From $149/mo on the 12-month plan (billed $1,788 every 12 months); $199 per 4 weeks on the monthly plan; same price at any dose (compounded tirzepatide, homepage-verified 2026-10-06)	Compounded, $125/mo on the annual plan (billed yearly). Verified 2026-08-21 (unchanged since 2026-07-14).
Key watchout	The $99 (semaglutide) and $149 (tirzepatide) figures are Sprout's 12-month plan rates, billed $1,188 and $1,788 every 12 months. The monthly plan is $149 (semaglutide) and $199 (tirzepatide) per 4 weeks, billed every 4 weeks, not per calendar month. Sprout states 'Same price at any dose.' Refund eligibility narrows once a provider has reviewed the intake (refund policy, read 2026-10-06).	The $99/mo semaglutide and $125/mo tirzepatide rates are the ANNUAL plan, BILLED YEARLY (semaglutide = $1,188 charged up front). A month-to-month rate is not published, confirm billing terms before enrolling.
Price checked	Checked by a person October 6, 2026 · an automated check re-read it October 15, 2026	Checked by a person August 21, 2026 · an automated check re-read it October 15, 2026

When to choose Sprout Health

You want a low compounded entry price with provider visit, medication and shipping included
You want a stated flat price at every dose (Sprout's own homepage statement)
You're comfortable choosing between a 12-month plan billed every 12 months and a monthly plan billed every 4 weeks
You may want to escalate dose with the same provider over time

Check current Sprout Health pricing →

When to choose Trimi

You want the lowest-cost compounded semaglutide ($99/mo) or tirzepatide ($125/mo) with everything bundled
You’re comfortable with an annual plan billed yearly ($1,188 up front for semaglutide)
You value an upfront '503A compounding pharmacy' and 'not FDA-approved' disclosure
You want care via a 50-state clinical network (Arora Health) with free shipping

Check current Trimi pricing →

Full reviews

Frequently asked questions

Is Sprout Health cheaper than Trimi?

Trimi starts lower on tirzepatide (Compounded, $125/mo on the annual plan (billed yearly). Verified 2026-08-21 (unchanged since 2026-07-14).). Higher doses can shift the picture, so confirm pricing at the dose you're likely to use long-term.

Which is better for semaglutide or tirzepatide, Sprout Health or Trimi?

Both Sprout Health and Trimi prescribe semaglutide and tirzepatide where appropriate. Choose based on how each program handles your target medication, not just the entry price.

Are Sprout Health and Trimi compounded or brand-name?

Sprout Health offers compounded semaglutide and tirzepatide; brand-name wegovy/zepbound listed cash-pay. Trimi offers compounded semaglutide and compounded tirzepatide, once-weekly at-home injection. If you specifically want brand-name Wegovy or Zepbound, lean toward whichever explicitly supports brand access; if compounded is fine, both can typically meet that need.

Can I switch from Sprout Health to Trimi?

Yes, switching between Sprout Health and Trimi is straightforward in most states. You typically finish your current month, complete a new intake with the other provider, and they handle the prescription. Watch for overlap on auto-renewal billing and confirm any dose-tier or formulation differences with the new clinician before your next shipment.

Compare Sprout Health and Trimi to other programs

Alert me when this gets cheaper

These prices move. Get one email when we publish a verified price drop, the programs on this list included. No spam. Unsubscribe any time.

Related guides

About compounded GLP-1 medicationsCompounded semaglutide and tirzepatide are not FDA-approved finished products. They are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not individually reviewed by the FDA for safety, effectiveness, or quality. Compounders describe these preparations as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms, semaglutide sodium or semaglutide acetate, that it considers different active ingredients from the approved drug, and has issued warning letters over marketing that presents a compounded preparation as interchangeable with an approved one. The FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so the shortage-era pathway for broad compounding of these drugs has ended. Compounding now proceeds under the ordinary rules: a 503A pharmacy compounding for an individual patient on a prescription, or a 503B outsourcing facility, which compounds in bulk under CGMP and FDA registration rather than per patient. Those rules generally do not cover a product that is “essentially a copy” of an approved drug unless a prescriber documents a change that makes a significant difference for an individual patient. Talk to a clinician about contraindications including personal or family history of medullary thyroid carcinoma or MEN 2. RangeYourself does not provide medical advice, does not guarantee a prescription, and does not guarantee weight-loss results.

RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Editorial recommendations are made independently. Pricing reflects publicly listed entry tiers, verified on the dates shown in the table above, and may change. Numbers like $99/mo on the 12-month plan (billed $1,188 every 12 months); $149 per 4 weeks on the monthly plan; same price at any dose (compounded semaglutide, homepage-verified 2026-10-06) and Compounded, $99/mo on the annual plan, BILLED YEARLY ($1,188/yr up front). Verified 2026-08-21 (unchanged since 2026-07-14). are starting tiers, not your guaranteed long-term cost.